These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10366042)

  • 1. Expression of the c-fos gene induced by parathyroid hormone in the bones of SAMP6 mice, a murine model for senile osteoporosis.
    Takeda N; Tsuboyama T; Kasai R; Takahashi K; Shimizu M; Nakamura T; Higuchi K; Hosokawa M
    Mech Ageing Dev; 1999 Apr; 108(1):87-97. PubMed ID: 10366042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural changes in bones of the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis.
    Chen H; Shoumura S; Emura S
    Histol Histopathol; 2004 Jul; 19(3):677-85. PubMed ID: 15168327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
    Tanaka S; Sakai A; Tanaka M; Otomo H; Okimoto N; Sakata T; Nakamura T
    J Bone Miner Res; 2004 Nov; 19(11):1813-20. PubMed ID: 15476581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo comparison of activated protein-1 gene activation in response to human parathyroid hormone (hPTH)(1-34) and hPTH(1-84) in the distal femur metaphyses of young mice.
    Stanislaus D; Devanarayan V; Hock JM
    Bone; 2000 Dec; 27(6):819-26. PubMed ID: 11113393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intermittent treatment with human Parathyroid Hormone 1-34 in SAMP6 senescence-accelerated mice.
    Washimi Y; Chen H; Ito A; Takao R; Uzawa T; Yamamoto Y; Yamada H; Shoumura S
    J Endocrinol Invest; 2010 Jun; 33(6):395-400. PubMed ID: 19915387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific bone loss in senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis.
    Chen H; Zhou X; Emura S; Shoumura S
    Exp Gerontol; 2009 Dec; 44(12):792-8. PubMed ID: 19815059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.
    Koh AJ; Demiralp B; Neiva KG; Hooten J; Nohutcu RM; Shim H; Datta NS; Taichman RS; McCauley LK
    Endocrinology; 2005 Nov; 146(11):4584-96. PubMed ID: 16081645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 gene haploinsufficiency reduces AP-1 gene expression without abrogating the anabolic effect of parathyroid hormone.
    Yu X; Milas J; Watanabe N; Rao N; Murthy S; Potter OL; Wenning MJ; Clapp WD; Hock JM
    Calcif Tissue Int; 2006 Mar; 78(3):162-70. PubMed ID: 16525748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of traditional Chinese medicine on bone loss in SAMP6: a murine model for senile osteoporosis.
    Chen H; Emura S; Isono H; Shoumura S
    Biol Pharm Bull; 2005 May; 28(5):865-9. PubMed ID: 15863895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids.
    Lee K; Deeds JD; Chiba S; Un-No M; Bond AT; Segre GV
    Endocrinology; 1994 Jan; 134(1):441-50. PubMed ID: 8275957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological study of the parathyroid gland and thyroid C cell in senescence-accelerated mouse (SAMP6), a murine model for senile osteoporosis.
    Chen H; Emura S; Yao XF; Shoumura S
    Tissue Cell; 2004 Dec; 36(6):409-15. PubMed ID: 15533456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Femoral peak bone mass and osteoclast number in an animal model of age-related spontaneous osteopenia.
    Okamoto Y; Takahashi K; Toriyama K; Takeda N; Kitagawa K; Hosokawa M; Takeda T
    Anat Rec; 1995 May; 242(1):21-8. PubMed ID: 7604978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of strain-specific femoral bone density by bone marrow-derived factors administered neonatally: a study on the spontaneously osteoporotic mouse, SAMP6.
    Takahashi K; Tsuboyama T; Matsushita M; Kasai R; Okumura H; Yamamuro T; Okamoto Y; Toriyama K; Kitagawa K; Takeda T
    Bone Miner; 1994 Mar; 24(3):245-55. PubMed ID: 8019211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse.
    Silva MJ; Brodt MD; Wopenka B; Thomopoulos S; Williams D; Wassen MH; Ko M; Kusano N; Bank RA
    J Bone Miner Res; 2006 Jan; 21(1):78-88. PubMed ID: 16355276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos.
    Demiralp B; Chen HL; Koh AJ; Keller ET; McCauley LK
    Endocrinology; 2002 Oct; 143(10):4038-47. PubMed ID: 12239115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of parathyroid hormone (1-34) on tibia in an adult rat model for chronic alcohol abuse.
    Sibonga JD; Iwaniec UT; Shogren KL; Rosen CJ; Turner RT
    Bone; 2007 Apr; 40(4):1013-20. PubMed ID: 17204460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice.
    Nakanishi R; Shimizu M; Mori M; Akiyama H; Okudaira S; Otsuki B; Hashimoto M; Higuchi K; Hosokawa M; Tsuboyama T; Nakamura T
    J Bone Miner Res; 2006 Nov; 21(11):1713-21. PubMed ID: 17002585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and molecular characterization of the senile osteoporosis in senescence-accelerated mouse prone 6 (SAMP6).
    Azuma K; Zhou Q; Kubo KY
    Med Mol Morphol; 2018 Sep; 51(3):139-146. PubMed ID: 29619545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.